Manipal Hospitals Targets $1 Billion IPO, Aiming to Be India’s Largest Healthcare Listing Yet

Manipal Health Enterprises is on the verge of launching what could become the largest hospital IPO in India’s history, targeting over $1 billion in proceeds with a valuation of approximately $12 billion. The company’s management is set to initiate a two-week investor roadshow aimed at both domestic and international investors starting next week. The offering is structured as a combination of a fresh issue of ₹8,000 crore and an Offer for Sale (OFS) of up to 4.32 crore shares by existing investors, including prominent names like Temasek and TPG. The shares are expected to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

Of the proceeds from the fresh issue, ₹5,378 crore is intended for reducing borrowings at Manipal Hospitals Private Limited, which stood at ₹10,612.79 crore as of January 31, 2026. This debt reduction is expected to positively impact the company’s profitability and balance sheet significantly. In addition, ₹574 crore will be allocated to finalize the acquisition of the minority stake in Sahyadri Hospitals, thus consolidating Manipal’s market position in Maharashtra. The presence of major investment banks like Kotak Mahindra Capital and Goldman Sachs overseeing the book suggests a well-structured offering that could attract substantial institutional interest.

The valuation of $12 billion would not only elevate Manipal above Max Healthcare as India’s most valuable hospital operator but also set a new standard for future healthcare IPOs in the country. With the private healthcare sector experiencing growth and increasing institutional interest, the timing seems opportune for such a significant listing. Retail investors are advised to keep a close eye on this IPO, especially considering the anticipated strong demand from Qualified Institutional Buyers (QIBs) and the potential positive indicators emerging from the grey market as the roadshow progresses.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)